Lipids

, Volume 29, Issue 3, pp 195–203 | Cite as

Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors

  • Pieter C. Dagnelie
  • Jimmy D. Bell
  • Steve C. R. Williams
  • Timothy E. Bates
  • Paul D. Abel
  • Christopher S. Foster
Article

Abstract

The aim of this study was to investigate whether tumor-induced cachexia and aberrations in host liver metabolism, induced by the MAT-LyLu variant of the Dunning prostate tumor, could be prevented by ω3 fatty acids from fish oil. On day 0, adult Copenhagen-Fisher rats fed normal chowad libitum were inoculated with 106 MAT-LyLu cells (n=14) or saline (n=9). On day 7, when tumors were palpable, four tumor-bearing (TB) and four nontumorbearing (NTB) rats were put on isocaloric diets with 50% of total energy as fish oil. The introduction of fish oil-enriched diets caused a reduction in energy intake to less than half of the energy intake by animals fed normal diets during days 7–14 (difference by dietary group: NTB,P<0.001; TB,P<0.001). During days 14–21, energy intake in fish oil-fed animals returned to approximately 75% of energy intake by animals fed normal diets (difference by dietary group: NTB,P<0.003; TB,P=0.001). Carcass weight of animals on day 21, when the study was terminated, was significantly related to initial weight (P=0.05) and mean food intake during the study (P=0.01). When data were adjusted for these variables using analysis of covariance, with NTB animals on normal diets being the reference group, significant loss of carcass weight was observed in TB animals on normal diets only (mean ±SEM 58±10 g loss,P<0.001), but not in TB animals on fish oil diets (8±18 g loss,P=0.67). This positive effect of fish oil diets on carcass weight in TB animals was statistically significant (50±19 g,P<0.02), implicating that the fish oil enriched diet inhibited tumor-induced weight loss by more than 85%. No effect of fish oil diets on tumor growth was detected. In all TB animals, regardless of diet, hepatic [Pi]/adenosine triphosphate] ratios measured by31P magnetic resonance spectroscopy (MRS)in vivo andin vitro were elevated, and absolute concentrations of phosphocholine, glycerophosphocho-line, glycerophosphoethanolamine and glucose-6-phosphate as determined by31P MRSin vitro were reduced. Ultrastructural studies of liver tissue revealed increased numbers of mitochondria and increased amounts of endoplasmic reticulum in the host liver of TB animals, without differences between dietary group. In conclusion, fish oil supplementation partially inhibited MAT-LyLu tumor-induced cachexia, but did not prevent the majority of31P MRS-detectable alterations in host liver metabolism.

Abbreviations

ADP

adenosine diphosphate

ATP

adenosine triphosphate

DHA

docosahexaenoic acid

EPA

eicosapentaenoic acid

F6P

fructose-6-phosphate

GPC

glycerophosphocholine

GPE

glycerophosphoethanolamine

G3P

glyceraldehyde-3-phosphate

G6P

glucose-6-phosphate

MRS

magnetic resonance spectroscopy

NTB

nontumor-bearing;sn-GP,sn-glycerol-3-phosphate

TB

tumor-bearing

TR

repetition time

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Galli, C., and Butrum, R. (1991)World Rev. Nutr. Diet. 66, 446–461.PubMedGoogle Scholar
  2. 2.
    Simopoulos, A.P. (1991)Am. J. Clin. Nutr. 54, 438–463.PubMedGoogle Scholar
  3. 3.
    Bégin, M.E. (1989)Nutrition, 5, 258–260.PubMedGoogle Scholar
  4. 4.
    Fernandes, G., and Venkatraman, J.T. (1991)World Rev. Nutr. Diet. 66, 488–503.PubMedGoogle Scholar
  5. 5.
    Cave, W.T. (1991)World Rev. Nutr. Diet 66, 462–476.PubMedGoogle Scholar
  6. 6.
    Borgeson, C.E., Pardini, L., Pardini, R.S., and Reitz, R.C. (1989)Lipids 24, 290–295.PubMedCrossRefGoogle Scholar
  7. 7.
    Man-Fan Wan, J., Kanders, B.S., Kowalchuk, M., Knapp, H., Szeluga, D.J., Bagley, J., and Blackburn, G.L. (1991)World Rev. Nutr. Diet. 66, 477–487.PubMedGoogle Scholar
  8. 8.
    Tisdale, M.J., and Dhesi, J.K. (1990)Cancer Res. 50, 5022–5026.PubMedGoogle Scholar
  9. 9.
    Dagneli, P.C., Bell, J.D., Williams, S.C.R., Bates, T.E., Abel, P.D., and Foster, C.S. (1993)Br. J. Cancer 67, 1303–1309.Google Scholar
  10. 10.
    Dagnelie, P.C., Bell, J.D., Williams, S.C.R., Cox, I.J., Menon, D.K., Sargentoni, J., and Coutts, G.A. (1993)NMR Biomed 6, 157–162.PubMedGoogle Scholar
  11. 11.
    Bashir, I., Sikora, K., and Foster, C.S. (1990)Biochem. Soc. Trans. 18, 968–969.PubMedGoogle Scholar
  12. 12.
    The Official Methods and Recommended Practices of the American Oil Chemists' Society (Firestone, D., ed.) 4th edn., pp. 1–2, American Oil Chemists' Society, Champaign.Google Scholar
  13. 13.
    Galloway, S.B. (ed.) (1989)Biomedical Test Materials Program: Drug Master Files for Biomedical Test Materials, Produced from Refined Menhaden Oil, and Their Placebos, p. 4.7, U.S. Department of Commerce, National Oceanic and Atmospheric Administration, and National Marine Fisheries Service, Washignton, D.C.Google Scholar
  14. 14.
    Bates, T.E., Williams, S.R., and Gadian, D.G. (1989)Magn. Res. Med. 12, 145–150.Google Scholar
  15. 15.
    Cox, I.J., Menon, D.K., Sargentoni, J., Bryant, D.J., Collins, A.G., Coutts, G.A., Iles, R.A., Bell, J.D., Benjamin, I.S., Gilbey, S., Hodgson, H.J.F., and Morgan, M.Y. (1992)J. Hepatol. 14, 265–275.PubMedCrossRefGoogle Scholar
  16. 16.
    Bates, T.E., Williams, S.R., Busza, A.A., and Gadian, D.G. (1988)NMR Biomed. 1, 67–73.PubMedGoogle Scholar
  17. 17.
    Bell, J.D., Cox, I.J., Peden, C.J., Menon, D.K., Sargentoni, J., Foster, C.S., Watanapa, P., Iles, R.A., and Uranjak, J. (1994)Biochem. Biophys. Acta, in press.Google Scholar
  18. 18.
    Millonig, G. (1961)J. Appl. Phys. 32, 1637 (Abstract B26).Google Scholar
  19. 19.
    Reynolds, E.S. (1963)J. Cell. Biol. 17, 208–212.PubMedCrossRefGoogle Scholar
  20. 20.
    Bibby, M.C., Double, J.A., Ali, S.A., Fearon, K.C.H., Brennan, R.A., and Tisdale, M.J. (1987)J. Natl. Cancer Inst. 78, 539–546.PubMedGoogle Scholar
  21. 21.
    Tisdale, M.J., and Beck, S.A. (1991)Biochem. Pharmacol. 41, 103–107.PubMedCrossRefGoogle Scholar
  22. 22.
    Tisdale, M.J. (1991)Br. J. Cancer 63, 337–342.PubMedGoogle Scholar
  23. 23.
    Otto, D.A., Tsai, C.E., Baltzell, J.K., and Wooten, J.T. (1991)Biochim. Biophys. Acta 1082, 37–48.PubMedGoogle Scholar
  24. 24.
    Dagnelie, P.C., Rietveld, T., Swart, G.R., Stijnen, Th., and Van den Berg, J.W.O. (1994)Lipids, 29, 41–45.PubMedGoogle Scholar
  25. 25.
    Halminski, M.A., Marsh, J.B., and Harrison, E.H. (1991)J. Nutr. 121, 1554–1561.PubMedGoogle Scholar

Copyright information

© American Oil Chemists’ Society 1994

Authors and Affiliations

  • Pieter C. Dagnelie
    • 1
  • Jimmy D. Bell
    • 2
  • Steve C. R. Williams
    • 3
  • Timothy E. Bates
    • 4
  • Paul D. Abel
    • 5
  • Christopher S. Foster
    • 6
  1. 1.Institute of Internal Medicine IIErasmus University of RotterdamRotterdamThe Netherlands
  2. 2.NMR Unit, Royal Postgraduate Medical SchoolHammersmith HospitalLondonUK
  3. 3.NMR Facility Department of ChemistryQueen Mary and Westfield CollegeLondonUK
  4. 4.Department of NeurochemistryInstitute of NeurologyLondonUK
  5. 5.Department of UrologyHammersmith HospitalLondonUK
  6. 6.Department of HistopathologyHammersmith HospitalLondonUK

Personalised recommendations